<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37599906</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Forming a consensus opinion to inform long COVID support mechanisms and interventions: a modified Delphi approach.</ArticleTitle><Pagination><StartPage>102145</StartPage><MedlinePgn>102145</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102145</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2023.102145</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Current approaches to support patients living with post-COVID condition, also known as Long COVID, are highly disparate with limited success in managing or resolving a well-documented and long-standing symptom burden. With approximately 2.1 million people living with the condition in the UK alone and millions more worldwide, there is a desperate need to devise support strategies and interventions for patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A three-round Delphi consensus methodology was distributed internationally using an online survey and was completed by healthcare professionals (including clinicians, physiotherapists, and general practitioners), people with long COVID, and long COVID academic researchers (round 1 n&#xa0;=&#xa0;273, round 2 n&#xa0;=&#xa0;186, round 3 n&#xa0;=&#xa0;138). Across the three rounds, respondents were located predominantly in the United Kingdom (UK), with 17.3-15.2% (round 1, n&#xa0;=&#xa0;47; round 2 n&#xa0;=&#xa0;32, round 2 n&#xa0;=&#xa0;21) of respondents located elsewhere (United States of America (USA), Austria, Malta, United Arab Emirates (UAE), Finland, Norway, Malta, Netherlands, Iceland, Canada, Tunisie, Brazil, Hungary, Greece, France, Austrailia, South Africa, Serbia, and India). Respondents were given &#x223c;5 weeks to complete the survey following enrolment, with round one taking place from 02/15/2022 to 03/28/22, round two; 05/09/2022 to 06/26/2022, and round 3; 07/14/2022 to 08/09/2022. A 5-point Likert scale of agreement was used and the opportunity to include free text responses was provided in the first round.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Fifty-five statements reached consensus (defined as &gt;80% agree and strongly agree), across the domains of i) long COVID as a condition, ii) current support and care available for long COVID, iii) clinical assessments for long COVID, and iv) support mechanisms and rehabilitation interventions for long COVID, further sub-categorised by consideration, inclusion, and focus. Consensus reached proposes that long COVID requires specialised, comprehensive support mechanisms and that interventions should form a personalised care plan guided by the needs of the patients. Supportive approaches should focus on individual symptoms, including but not limited to fatigue, cognitive dysfunction, and dyspnoea, utilising pacing, fatigue management, and support returning to daily activities. The mental impact of living with long COVID, tolerance to physical activity, emotional distress and well-being, and research of pre-existing conditions with similar symptoms, such as myalgic encephalomyelitis, should also be considered when supporting people with long COVID.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">We provide an outline that achieved consensus with stakeholders that could be used to inform the design and implementation of bespoke long COVID support mechanisms.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomedical and Clinical Science Research Theme, School of Human Sciences, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>Ruth E M</ForeName><Initials>REM</Initials><AffiliationInfo><Affiliation>Biomedical and Clinical Science Research Theme, School of Human Sciences, University of Derby, Derby, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Living for Pandemic Event Protection Network (HL-Pivot), USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Francesco V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Biomedical and Clinical Science Research Theme, School of Human Sciences, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skipper</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement and Engagement Representative, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bewick</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Uttoxeter Road, Derby DE22 3NE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leighton</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham and Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Bethan E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham and Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faghy</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Biomedical and Clinical Science Research Theme, School of Human Sciences, University of Derby, Derby, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Living for Pandemic Event Protection Network (HL-Pivot), USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic disease</Keyword><Keyword MajorTopicYN="N">Functional status</Keyword><Keyword MajorTopicYN="N">Global health</Keyword><Keyword MajorTopicYN="N">Lived experience</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>All authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37599906</ArticleId><ArticleId IdType="pmc">PMC10432807</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.102145</ArticleId><ArticleId IdType="pii">S2589-5370(23)00322-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Office for National Statistics  . 2022. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 3 November 2022.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022 Available from:</Citation></Reference><Reference><Citation>World Health Organisation  . 2021. Coronavirus disease (COVID-19): post COVID-19 condition.https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition Available from:</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(6):408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  . 2021. Post COVID-19 condition clinical case definition.https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Available from:</Citation></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made long covid. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M., Rayner C., Freyer A., et al. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. 2021;71(712):e815&#x2013;e825. doi: 10.3399/BJGP.2021.0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S., Abbafati C., Aerts J.G., et al. A&#xa0;global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022 doi: 10.1101/2022.05.26.22275532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D.A., O&#x2019;Brien K.K. Conceptualising long COVID as an episodic health condition. BMJ Glob Health. 2021;6(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn A.V.W., Guy G.W., Brysch W., Bell J.D. Understanding long COVID; mitochondrial health and adaptation&#x2014;old pathways, new problems. Biomedicines. 2022;10(12):3113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A&#xa0;central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D., Stein S., Ramelli S., et al. SARS-CoV-2 infection and persistence throughout the human body and brain. Res Square. 2021;12(7941):758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks E.F., Bhatt A.S. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Cold Spring Harb Mol Case Stud. 2021;7(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040733</ArticleId><ArticleId IdType="pubmed">33593727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71(1):226&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarpak L., Pruc M., Filipiak K.J., et al. Myocarditis: a complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology. Cardiol J. 2022;29(1):178&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8890406</ArticleId><ArticleId IdType="pubmed">34811716</ArticleId></ArticleIdList></Reference><Reference><Citation>Price L.C., Garfield B., Bloom C., et al. Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography. ERJ Open Res. 2022;8(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548240</ArticleId><ArticleId IdType="pubmed">36447736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.E., Feng A., Meng W., et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12(1):5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., et al.  Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1. http://europepmc.org/abstract/MED/35078982 https://europepmc.org/articles/PMC8789854 https://europepmc.org/articles/PMC8789854?pdf=render Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Haleeqa M., Alshamsi I., Al Habib A., et al. Optimizing supportive care in COVID-19 patients: a multidisciplinary approach. J&#xa0;Multidiscip Healthc. 2020;13:877&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471338</ArticleId><ArticleId IdType="pubmed">32943872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., et al. Developing services for long COVID: lessons from a study of wounded healers. Clin Med. 2021;21(1):59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850205</ArticleId><ArticleId IdType="pubmed">33479069</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Craig D., Fu Y. Mental health services in response to the COVID-19 pandemic in high-income countries: protocol for a rapid review. BMJ Open. 2022;12(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247322</ArticleId><ArticleId IdType="pubmed">35772830</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K., Yahyouche A., Haroon S., Camaradou J., Turner G. Long COVID and self-management. Lancet. 2022;399(10322):355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Owen R., Thomas C., et al. Is long COVID the next global health crisis? J&#xa0;Glob Health. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9597397</ArticleId><ArticleId IdType="pubmed">36285549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasson F., Keeney S., McKenna H. Research guidelines for the Delphi survey technique. J&#xa0;Adv Nurs. 2000;32(4):1008&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pubmed">11095242</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett D., Heale R. What are Delphi studies? Evid Base Nurs. 2020;23(3):68&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">32430290</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon W. The Delphi technique: a review. Int J Ther Rehabil. 2009;16(2):69&#x2013;76.</Citation></Reference><Reference><Citation>Boereboom C.L., Williams J.P., Leighton P., Lund J.N. Forming a consensus opinion on exercise prehabilitation in elderly colorectal cancer patients: a Delphi study. Tech Coloproctol. 2015;19(6):347&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">25972298</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederberger M., Spranger J. Delphi technique in health sciences: a map. Front Public Health. 2020;8:457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536299</ArticleId><ArticleId IdType="pubmed">33072683</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Holland A.E., Singh S.J., Tonia T., Wilson K.C., Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated international task force. Eur Respir J. 2020;56(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson K.R., Leighton P., Logan P., et al. Developing the principles of chair based exercise for older people: a modified Delphi study. BMC Geriatr. 2014;14(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039312</ArticleId><ArticleId IdType="pubmed">24884392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasa P., Jain R., Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 2021;11(4):116&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299905</ArticleId><ArticleId IdType="pubmed">34322364</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna H.P. The Delphi technique: a worthwhile research approach for nursing? J&#xa0;Adv Nurs. 1994;19(6):1221&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">7930104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V., Gao M., West E.A., et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57(5):418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. NICE backtracks on graded exercise therapy and CBT in draft revision to CFS guidance. BMJ. 2020;371</Citation><ArticleIdList><ArticleId IdType="pubmed">33172928</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. NICE cautions against using graded exercise therapy for patients recovering from Covid-19. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32694164</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., et al. Characteristics and impact of long covid: findings from an online survey. PLoS One. 2022;17(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Ashton R.E.M., Maden-Wilkinson T.M., et al. Integrated sports and respiratory medicine in the aftermath of COVID-19. Lancet Respir Med. 2020;8(9):852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347343</ArticleId><ArticleId IdType="pubmed">32653073</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Arena R., Stoner L., et al. The need for exercise sciences and an integrated response to COVID-19: a position statement from the international HL-PIVOT network. Prog Cardiovasc Dis. 2021;67:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859729</ArticleId><ArticleId IdType="pubmed">33549590</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Sylvester K.P., Cooper B.G., Hull J.H. Cardiopulmonary exercise testing in the COVID-19 endemic phase. Br J Anaesth. 2020;125(4):447&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287473</ArticleId><ArticleId IdType="pubmed">32571569</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>